Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to new results. Patients with newly diagnosed atrial fibrillation benefit from early rhythm ...
Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. In a ...
Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial fibrillation are associated with increased risks of thromboembolism and heart failure. Catheter ablation as ...
Type 1 diabetes (T1D) can be especially difficult to manage in older adults, so this new multinational review compared the safety and effectiveness of a hybrid closed-loop (HCL) system and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results